Table 1 Summary of developmental cohort used for experiments
From: Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex
Group | Age (years) | Gender | pH | PMI | RIN | n |
|---|---|---|---|---|---|---|
Microarray | ||||||
Neonate | 0.11 - 0.24 | 2F, 5M | 6.60 ± 0.05 | 22.71 ± 2.40 | 7.27 ± 0.18 | 7 |
Infant | 0.25 - 0.91 | 2F, 6M | 6.69 ± 0.05 | 17.63 ± 2.72 | 7.57 ± 0.17 | 8 |
Toddler | 1.58 - 4.86 | 3F, 3M | 6.74 ± 0.07 | 25.67 ± 3.90 | 6.91 ± 0.24 | 6 |
School Age | 7.84 - 12.97 | 3F, 3M | 6.73 ± 0.06 | 14.67 ± 2.22 | 7.03 ± 0.31 | 6 |
Teenage | 16.34 - 17.82 | 1F, 4M | 6.75 ± 0.05 | 18.40 ± 2.16 | 6.26 ± 0.53 | 5 |
Young Adult | 20.14 - 25.38 | 2F, 4M | 6.75 ± 0.07 | 12.00 ± 2.21 | 6.91 ± 0.24 | 6 |
Adult | 35.99 - 49.22 | 2F, 4M | 6.68 ± 0.09 | 13.83 ± 2.18 | 6.78 ± 0.25 | 6 |
qPCR | ||||||
Neonate | 0.11 - 0.24 | 4F, 5M | 6.56 ± 0.05 | 22.11 ± 1.88 | 7.01 ± 0.27 | 9 |
Infant | 0.25 - 0.91 | 5F, 8M | 6.61 ± 0.05 | 17.46 ± 1.76 | 7.19 ± 0.19 | 13 |
Toddler | 1.58 - 4.86 | 4F, 4M | 6.77 ± 0.06 | 19.25 ± 1.89 | 6.85 ± 0.25 | 8 |
School Age | 7.84 - 12.97 | 4F, 3M | 6.69 ± 0.07 | 14.43 ± 1.95 | 6.88 ± 0.24 | 7 |
Teenage | 15 - 17.69 | 2F, 5M | 6.74 ± 0.03 | 17.86 ± 1.47 | 6.60 ± 0.28 | 7 |
Young Adult | 20.14 - 25.38 | 3F, 6M | 6.67 ± 0.08 | 13.67 ± 2.75 | 6.73 ± 0.22 | 9 |
Adult | 35.99 - 49.22 | 3F, 5M | 6.60 ± 0.10 | 13.38 ±1 .63 | 6.53 ± 0.27 | 8 |
In situ hybridisation | ||||||
Neonate | 0.11 - 0.24 | 4F, 5M | 6.60 ± 0.05 | 22.11 ± 1.88 | 7.01 ± 0.27 | 9 |
Infant | 0.25 - 0.91 | 5F, 8M | 6.61 ± 0.05 | 17.46 ± 1.76 | 7.20 ± 0.19 | 13 |
Toddler | 1.58 - 4.86 | 5F, 4M | 6.74 ± 0.06 | 22.00 ± 3.22 | 6.83 ± 0.22 | 9 |
School Age | 7.84 - 12.97 | 4F, 3M | 6.69 ± 0.07 | 14.43 ± 1.95 | 6.88 ± 0.24 | 7 |
Teenage | 15 - 17.69 | 2F, 4M | 6.75 ± 0.04 | 16.67 ± 1.02 | 6.64 ± 0.33 | 6 |
Young Adult | 21.93 - 25.38 | 3F, 4M | 6.67 ± 0.09 | 14.43 ± 3.20 | 6.83 ± 0.25 | 7 |
Adult | 35.99 – 48.69 | 1F, 4M | 6.45 ± 0.10 | 12.60 ± 1.60 | 6.39 ± 0.35 | 5 |